Emmaus Life Sciences Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Emmaus Life Sciences Inc's ROI in the fourth quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Emmaus Life Sciences Inc 's return on investment (ROI) in its fourth quarter of 2025

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2025) IV. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-17	-39	-42	-10	-37
Return On Investment (TTM)	-	-	-	-	-
EMMAW's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-7	-3	-4	-6	-3

EMMAW Company Profile >> Back to EMMAW Roi Comparisons >> See Annual EMMAW Return On Investment

Return On Investment EMMAW's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Emmaus Life Sciences Inc's IV. Quarter Investments	$ -17 Millions	EMMAW's Balance sheet
Emmaus Life Sciences Inc's IV. Quarter Income	$ -2 Millions	Quarterly EMMAW's Income Statement
EMMAW's Income by Division		See EMMAW's Income by Division

EMMAW Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	-48	-40	-26	-6	20
Y / Y Investment Growth	-	-	-	-	-39.52 %
Net Income in Millions	-7	-6	-4	-11	-16
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-	-81.22 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EMMAW's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EMMAW's Competitors
Subscribers only: Roi for Emmaus Life Sciences Inc's Suppliers
Subscribers only: Return On Investment for EMMAW's Customers

Other Ratios
EMMAW's Roa	EMMAW's Inventory Turnover Ratio	EMMAW's Growth Rates	EMMAW's Dividend Statistics
	EMMAW's Profitability Ratios	EMMAW's Asset Turnover Ratio	EMMAW's Dividend Growth
EMMAW's Roe	EMMAW's Valuation Ratios	EMMAW's Financial Strength Ratios	EMMAW's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector	ROI
Exelixis Inc	71.31 %
Entera Bio Ltd	63.91 %
Tg Therapeutics Inc	63.77 %
Aurinia Pharmaceuticals Inc	56.37 %
Pulmatrix Inc	53.09 %
Novavax inc	51.88 %
Q32 Bio Inc	50.33 %
Idexx Laboratories Inc	48.69 %
Theravance Biopharma inc	46.03 %
Elite Pharmaceuticals Inc	45.80 %
Enlivex Therapeutics Ltd	45.75 %
Gsk Plc	44.94 %
Galmed Pharmaceuticals Ltd	43.72 %
Abeona Therapeutics Inc	42.25 %
Alpha Tau Medical Ltd	42.04 %
Dariohealth Corp	41.31 %
Acadia Pharmaceuticals Inc	39.64 %
Medinotec Inc	37.45 %
Zevra Therapeutics Inc	36.78 %
Oramed Pharmaceuticals Inc	35.86 %
Ptc Therapeutics inc	35.12 %
Mettler toledo International Inc	34.74 %
Newgenivf Group Limited	32.05 %
Eli Lilly And Company	31.62 %
Indivior Pharmaceuticals Inc	31.00 %
Hutchmed china Limited	30.87 %
Medpace Holdings Inc	30.44 %
Adma Biologics Inc	28.75 %
Carlisle Companies Incorporated	27.24 %
Incyte Corporation	27.08 %

Date modified: 2026-09-08T15:11:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.